Angiographic Delivery of AD-MSC for Ulcerative Colitis
NCT04312113
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Adipose derived, autologous mesenchymal stem cells
Sponsor
Mayo Clinic